Pharmosa Biopharm (ROCO:6875) Interest Expense : NT$-2.4 Mil (TTM As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Pharmosa Biopharm Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Pharmosa Biopharm's interest expense for the three months ended in Dec. 2024 was NT$ -0.6 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-2.4 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Pharmosa Biopharm's Operating Income for the three months ended in Dec. 2024 was NT$ 14.3 Mil. Pharmosa Biopharm's Interest Expense for the three months ended in Dec. 2024 was NT$ -0.6 Mil. Pharmosa Biopharm's Interest Coverage for the quarter that ended in Dec. 2024 was 24.89. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Pharmosa Biopharm Interest Expense Historical Data

The historical data trend for Pharmosa Biopharm's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmosa Biopharm Interest Expense Chart

Pharmosa Biopharm Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-3.86

-1.21

-0.65

-2.86

-2.42

Pharmosa Biopharm Quarterly Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial												-1.22	-0.64	-0.57	-0.63	-0.57

Pharmosa Biopharm Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-2.4 Mil.

Pharmosa Biopharm (ROCO:6875) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Pharmosa Biopharm's Interest Expense for the three months ended in Dec. 2024 was NT$-0.6 Mil. Its Operating Income for the three months ended in Dec. 2024 was NT$14.3 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was NT$99.6 Mil.

Pharmosa Biopharm's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2024 )	/	Interest Expense (Q: Dec. 2024 )
	=	-1	*	14.261	/	-0.573
	=	24.89

The higher the ratio, the stronger the company's financial strength is.

Pharmosa Biopharm Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmosa Biopharm Inc (ROCO:6875) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.66, Sanchong Road, 3rd Floor-3, Nangang District, Taipei, TWN, 11502

Website

https://www.pharmosa.com.tw

Pharmosa Biopharm Inc is a world-class biotechnology company focusing on developing a new drug by exploiting proprietary formulation and manufacturing technology.

Pharmosa Biopharm Headlines

No Headlines